Is the FDA Too Cautious?
Open to Debate
The Future of Drug Regulation
"I'm arguing for that balance to be in a different place," he says. "You can't talk about efficacy or the fact it works without talking about personalized medicine" The question is, what could the FDA become as the world leader in regulatory science? Do you want to respond? I have a question for you, but I want to do a genomics.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
